Innate Pharma Stock Pattern Recognition Three Advancing White Soldiers

IPHA Stock  USD 1.54  0.04  2.67%   
Innate Pharma pattern recognition tool provides the execution environment for running the Three Advancing White Soldiers recognition and other technical functions against Innate Pharma. Innate Pharma value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of pattern recognition indicators. As with most other technical indicators, the Three Advancing White Soldiers recognition function is designed to identify and follow existing trends. Innate Pharma momentum indicators are usually used to generate trading rules based on assumptions that Innate Pharma trends in prices tend to continue for long periods.

Recognition
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twelve with a total number of output elements of fourty-nine. The function did not return any valid pattern recognition events for the selected time horizon. The Three Advancing White Soldiers indicator describes Innate Pharma market reversal pattern.

Innate Pharma Technical Analysis Modules

Most technical analysis of Innate Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Innate from various momentum indicators to cycle indicators. When you analyze Innate charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Innate Pharma Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Innate Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innate Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Innate Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innate Pharma's daily price indicators and compare them against related drivers, such as pattern recognition and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Innate Pharma's intrinsic value. In addition to deriving basic predictive indicators for Innate Pharma, we also check how macroeconomic factors affect Innate Pharma price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2023 2024 (projected)
Dividend Yield0.0024670.002344
Price To Sales Ratio4.063.86
Hype
Prediction
LowEstimatedHigh
0.081.536.59
Details
Intrinsic
Valuation
LowRealHigh
0.153.028.08
Details
Naive
Forecast
LowNextHigh
0.031.466.52
Details
5 Analysts
Consensus
LowTargetHigh
6.877.558.38
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Innate Pharma. Your research has to be compared to or analyzed against Innate Pharma's peers to derive any actionable benefits. When done correctly, Innate Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Innate Pharma.

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Earnings Calls Now

   

Earnings Calls

Check upcoming earnings announcements updated hourly across public exchanges
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Momentum Idea
Momentum
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 60 shares
Business Services Idea
Business Services
Invested few shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
When determining whether Innate Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innate Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innate Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innate Pharma Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innate Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For information on how to trade Innate Stock refer to our How to Trade Innate Stock guide.
You can also try the Stocks Directory module to find actively traded stocks across global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innate Pharma. If investors know Innate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innate Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.75)
Earnings Share
(0.44)
Revenue Per Share
0.419
Quarterly Revenue Growth
(0.69)
Return On Assets
(0.14)
The market value of Innate Pharma is measured differently than its book value, which is the value of Innate that is recorded on the company's balance sheet. Investors also form their own opinion of Innate Pharma's value that differs from its market value or its book value, called intrinsic value, which is Innate Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innate Pharma's market value can be influenced by many factors that don't directly affect Innate Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innate Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innate Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innate Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.